The COVID-19-N-antigen rapid test is a side current immunoassay based on the principle of double-antibody technology. The test is used for the fast and qualitative detection of antigen against COVID-19 / SARS-Cov-2 in anterior nasal (anterior nasal area), – smears. The antigen is usually detectable in the anterior nasal area, in the nasal and throat area as well as in the throat during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is required to determine infection status. Positive results do not exclude a bacterial infection or co-infection with other viruses. The proven pathogen may not be the definitive cause of the disease. Negative results do not exclude infection with SARS-CoV-2 and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in relation to a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19 and confirmed with a molecular test if necessary for patient management.
The COVID-19 antigen rapid test is intended for use by non-professionals.
Sensitivity: > 98.4%
Specificity: > 98.8%
Match: > 98.7%
The result is displayed after 15 – 20 minutes.
How does detection work?
The N protein of the SARS-Cov-2 virus reacts with the strip-shaped coating of the test line and, in the presence of a viral load, leads to a color change, i.e. a red line appears in the area of the test line (T). If the sample taken does not contain virus proteins or antigens, no red test line (T) will occur.
Professional storage and disposal
Storage at room temperature (10 – 25°C).
Dispose of the residual waste in a professional manner after use.
Scope of delivery:
5x test strip (individually in a foil bag)
5x extraction buffer
5x dispenser cap
5x instruction manual